NACDS kicks off Marketplace Conference with successful programs
SAN DIEGO The National Association of Chain Drug Stores’ 2010 Marketplace Conference kicked off this weekend with exclusive discussions and meet-and-greets, connecting the nation’s top retailers and suppliers.
The conference’s programs, including Meet the Market — a program that featured nearly 8,000 preplanned appointments for one-on-one meetings to discuss suppliers’ products and services — and “Meet the Retailer/How to Do Business With…” sessions — which featured exclusive discussions with leading retail companies — were just some of the successful highlights held over the weekend. Additionally, many exhibitors also prominently displayed their new products in the “Product Showcase” on the exhibit hall floor on Sunday.
Meanwhile, CVS Caremark president and COO Larry Merlo, who currently serves as NACDS chairman, addressed a meeting of the NACDS Retail Advisory Board, which included presentations on consumer marketing.
“This year’s NACDS Marketplace Conference is full of high energy and productivity,” said NACDS president and CEO Steve Anderson. “The top-notch programming and speakers, and exhibitor enthusiasm, are resulting in positive experiences for retailers and suppliers. We look forward to continued successful business opportunities for all attendees.”
Pennsylvania boosts pharmacists’ role; NACDS hails bid for collaboration
ALEXANDRIA, Va. In a gesture hailed by retail pharmacy advocates, the Keystone State is moving to expand the role its pharmacists play in improving patient health and outcomes.
The move comes with enactment of a Pennsylvania law, H.B. 1041, which will open new opportunities for collaborative medication therapy management between physicians and pharmacists on behalf of patients in a community pharmacy setting. Previously, such team approaches were permitted only in such institutional settings as hospitals and nursing homes in the state.
The National Association of Chain Drug Stores had high praise for the new law, calling it an “important victory,” and citing the efforts made by the Pennsylvania Association of Chain Drug Stores and the Pennsylvania Pharmacists Association toward its passage. “With the enactment of this legislation, Pennsylvania has said ‘yes’ to improving the health and lives of patients, and to reducing overall healthcare costs,” said NACDS president and CEO Steve Anderson. “This new law recognizes the expertise of pharmacists, the accessibility of community pharmacy and the ability of pharmacists to help patients properly manage their health conditions for the well-being of patients and for the good of society.”
Pennsylvania is the 33rd state to allow collaborative drug therapy management in the community setting, according to NACDS research. “Nine states allow it in institutional settings only, and eight do not allow it at all,” noted the group Friday.
Taro receives FDA approval for Kytril generic
HAWTHORNE, N.Y. Taro Pharmaceutical Industries has received approval from the Food and Drug Administration to market its generic version of a drug used to prevent nausea and vomiting in patients on chemotherapy, the Israeli generic drug maker said Friday.
The FDA approved Taro’s granisetron hydrochloride tablets in the 1-mg strength. The tablets are a generic version of Roche’s Kytril tablets.
Granisetron tablets had sales of around $15 million in 2009, according to unnamed industry sources cited by Taro.